- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 3.91M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 3.21M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 80.94K sh |
| Capex | Q1 2026 · Mar 31, 2026 | $71.88K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.21M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.79M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $14.11M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $10.7M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $12.99M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $8.86M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $2.88M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $4.71M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.42M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.06M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.72M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $14.21M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $10.81M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $15.04M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $11.58M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$2.71 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$25.34 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$2.71 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$25.34 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.72M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.24M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $1.38M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $858.83K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$3.01M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.05M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$3.09M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.09M |